Non-Infectious

IZOKIBEP (IL-17A)

Oct 07 2022

To assess the safety, tolerability, and immunogenicity of izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uveitis requiring high-dose steroids.

Read More